Blood Culture Test Market to Touch US$ 7.1 Billion by 2027, at a CAGR of 8.77%

According to the latest report by IMARC Group "Blood Culture Test Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", The global blood culture test market reached a value of US$ 4.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7.1 Billion by 2027, exhibiting a CAGR of 8.77% during 2022-2027.

A blood culture test represents a medical procedure that is conducted to diagnose bacterial, fungal, and mycobacterial infections. It is performed for the identification of numerous microorganisms in the blood sample and to prevent the development of sepsis conditions. The results of the test can aid in determining the particular pathogens that are causing the infection and various possible ways of combating the disease. In line with this, blood culture test uses products, including blood culture media, assay kits, reagents, blood culture instruments and accessories, such as automated blood culture systems and supporting laboratory equipment, etc. Consequently, they are gaining extensive traction among hospital laboratories.

Request for a free sample copy of this report: https://www.imarcgroup.com/blood-culture-test-market/requestsample

 We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Blood Culture Test Market Trends and Drivers:

The rising prevalence of chronic diseases across countries is primarily augmenting the blood culture test market. Furthermore, the expanding geriatric population who are more susceptible to sepsis and other medical ailments is positively influencing the global market. Apart from this, the escalating demand for blood culture tests to analyze specimens, on account of the sudden outbreak of the COVID-19 pandemic, is acting as another significant growth-inducing factor. Moreover, the widespread adoption of these tests by laboratories, diagnostic centers, and other healthcare institutes for detecting the presence of antibodies in the blood as well as identifying and isolating the infected individuals, is also bolstering the market growth. Besides this, the growing consumer health consciousness, continuous improvements in the healthcare infrastructures, and extensive R&D activities in the field of medical sciences are expected to fuel the blood culture test market in the coming years.

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

Abbott Laboratories (ABT)
Beckman Coulter ( BEC )
BD (Becton, Dickinson and Company) (NYSE:BDX)
BIOMERIEUX (BIM.PA)
Bruker Corporation (BRKR)
Cepheid (NASDAQ:CPHD). (Danaher Corporation)
Luminex Corporation
Merck Group
Siemens Healthineers AG
Roche Diagnostics
T2 Biosystems, Inc. (TTOO)
Thermo Fisher Scientific Inc. (NYSE: TMO)

Explore full report with table of contents: https://www.imarcgroup.com/blood-culture-test-market

The report has segmented the market on the basis of Product Type, End-User and Region.

Breakup by Testing Method:

Conventional
Automated 

Breakup by Product:

Consumables
Blood Culture Media
Aerobic Blood Culture Media
Anaerobic Blood Culture Media
Fungi/Yeast Blood Culture Media
Mycobacteria Blood Culture Media
Assay Kits and Reagents
Blood Culture Accessories 
Instruments
Automated Blood Culture Systems
Supporting Laboratory Equipment
Incubators
Colony Counters
Microscopes
Gram Stainers
Software and Services

Breakup by Technology:

Culture-based Technology
Molecular Technology
Microarray
PCR
PNA-FISH
Proteomic Technology
Others

Breakup by Application:

Bacterial Infection
Fungal Infection
Mycobacterial Infection

Breakup by End-User:

Hospital Laboratories
Reference Laboratories
Research Laboratories
Others

Market Breakup by Region:

North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa

Note: We are updating our reports, if you want the report with the latest primary and secondary data (2023-2028) including industry trends, market size and competitive landscape, etc. click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Contact US

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.